Follow
Q4: 2026-02-26 Earnings Summary
EPS of $0.36 beats by $0.89
| Revenue of $665.50M (39.79% Y/Y) beats by $64.82M
Natera, Inc. (NTRA) 47th Annual Raymond James Institutional Investor Conference March 4, 2026 1:05 PM EST
Company Participants
Mike Brophy – Chief Financial Officer
Conference Call Participants
Andrew Cooper – Raymond James & Associates, Inc., Research Division
Presentation
Andrew Cooper
Raymond James & Associates, Inc., Research Division
Good afternoon, everyone. Thanks for joining us for the final day of the Raymond James Institutional Investor Conference. For those who don’t know me, I’m Andrew Cooper, cover Diagnostics and Life Science tools for Raymond James. Happy to have Natera CFO, Mike Brophy, with me this afternoon. We’re going to do a little bit of fireside chat, and then we’ll head downstairs for a breakout in Amarante 1 afterwards. So please join us there.
Question-and-Answer Session
Andrew Cooper
Raymond James & Associates, Inc., Research Division
But maybe just to start, Mike, can you give folks who are maybe a little bit newer to the story, a couple of minutes on just who Natera is, where you fit in the landscape and some of the topical items of late?
Mike Brophy
Chief Financial Officer
Yes. No, thanks for having me. So always great to be here. We just announced our Q4 results. So that’s always a good call because it’s a great kind of recap of 2025 and you get to set the guide and expectations for ’26. I think that was very well received. Well we did it.
I mean, just maybe just a quick summary. In the quarter, we had another fantastic kind of revenue growth quarter. Signatera volumes where you had another kind of record absolute quarter and also a record kind of just growth unit quarter as well. Gross margins were extremely strong in the quarter. All in, we were — I think we’re about 67% and then even backing up the true-ups, we were close to 64% for gross margins
GIPHY App Key not set. Please check settings